Through her work as a clinician-researcher focused on understanding the determinants of diabetes, Institute Associate Professor Marie-France Hivert is looking to precision medicine as the key to unlocking more precise diagnostic, prevention, and treatment strategies for the disease than exist today. From postdoctoral fellowship to leading research and teaching activities, Dr. Hivert’s efforts have made significant contributions to advancing knowledge of precision medicine as a viable means of improving the lives of those suffering from, or at risk of, diabetes.
As the opioid crisis continues, research on measures taken to alleviate it is much needed. Such research is one component of the Division of Health Policy and Insurance Research (HPI) portfolio.
Hefei Wen leads the division’s research on the implications of opioid regulation. Dr. Wen's work has been among the first to examine the behavioral health implications of Medicaid expansions, marijuana liberalization policies, prescription drug monitoring programs, opioid prescribing limit laws, and buprenorphine waiver requirements, especially in the context of the U.S. opioid crisis.